New blood test could spot autoimmune diseases earlier
NCT ID NCT07188285
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will use a special blood test called mass spectrometry to look at immune cells in 500 people with various autoimmune diseases and healthy volunteers. The goal is to find patterns that could help doctors diagnose these conditions sooner. No treatments are being tested; this is purely a research study to gather information.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a new blood test that helps doctors diagnose autoimmune diseases earlier and more accurately.
- What could go wrong
- This is an observational study, not a treatment trial. It may not result in a practical diagnostic tool, and findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANCA-ASSOCIATED VASCULITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can skin biopsies unlock new treatments for scleroderma?
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Can discarded bone reveal the secrets to stronger bones?
- Could a skin patch ease stomach pain in scleroderma?
- Could a painless microneedle pad ease Raynaud's in scleroderma?
- Could a simple blood test flag heart risk in rheumatoid arthritis?